Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
| Author | |
|---|---|
| Abstract |
:
To report 4-year imaging outcomes in the RAPID-axSpA (NCT01087762) study of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA), treated with certolizumab pegol (CZP). |
| Year of Publication |
:
2018
|
| Journal |
:
Annals of the rheumatic diseases
|
| Date Published |
:
2018
|
| ISSN Number |
:
0003-4967
|
| URL |
:
http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=29343510
|
| DOI |
:
10.1136/annrheumdis-2017-212377
|
| Short Title |
:
Ann Rheum Dis
|
| Download citation |
